cadmium has been researched along with Lymphoma, B-Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, J; Liao, J; Liu, J; Lv, Y; Zeng, L; Zhang, C; Zhang, W; Zong, C | 1 |
Bergdahl, IA; Botsivali, M; Chadeau-Hyam, M; Johansson, AS; Kelly, RS; Kyrtopoulos, SA; Lundh, T; Palli, D; Porta, M; Vermeulen, R; Vineis, P | 1 |
Biaglow, JE; Chawannakul, D; Hacia, JG; Ho, VV; Karaman, MW; Lecane, P; Lepp, C; Magda, D; Mesfin, M; Miles, D; Miller, RA; Nagpal, S | 1 |
3 other study(ies) available for cadmium and Lymphoma, B-Cell
Article | Year |
---|---|
The role of miRNAs in regulating the effect of prenatal cadmium exposure on ovarian granulosa cells in a transgenerational manner in female rats.
Topics: Animals; Cadmium; Female; Gene Expression Regulation; Granulosa Cells; Lymphoma, B-Cell; MicroRNAs; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 2021 |
Blood erythrocyte concentrations of cadmium and lead and the risk of B-cell non-Hodgkin's lymphoma and multiple myeloma: a nested case-control study.
Topics: Cadmium; Case-Control Studies; Cohort Studies; Environmental Exposure; Erythrocytes; Female; Humans; Italy; Lead; Lymphoma, B-Cell; Male; Middle Aged; Multiple Myeloma; Risk Factors; Sweden | 2013 |
Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines.
Topics: Acetates; Antineoplastic Agents; Cadmium; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Gene Expression; Gene Expression Profiling; Humans; Lung Neoplasms; Lymphoma, B-Cell; Male; Metalloporphyrins; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Thioctic Acid; Zinc; Zinc Acetate | 2005 |